products, technologies and practices in the management of vision disorders and eye-related diseases
The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice.
Below is a sample of surgical sealants, glues and wound closure applications by clinical area:
Source: MedMarket Diligence, LLC; [...]
The use of autologous, allogeneic and xenogeneic cells and tissues, the use of biomaterials, cell scaffolding and other approaches to tissue repair and regeneration has become part of arsenal of a number of clinical specialties, with high caseload and market revenue in these areas. In particular, orthopedics and skin applications are well established. And, while [...]
Our research into the products, technologies, companies and markets for tissue engineering and cell therapy has revealed that the 2009 market was at $6.9 billion. The market has grown dramatically, in commercialized products and company activity, over the past few years and is on an accelerated growth rate as technology hurdles are overcome and clinical [...]
The number of companies with approved products and measurable revenues in the field of cell therapy and tissue engineering has exceeded the expectation of many (though not all) in the industry.
Markets such as cell/tissue are often characterized by overestimated evaluations of commercial potential and underestimated consideration of the actual challenges. Indeed many technology challenges remain [...]
Applications of fibrin sealant are gaining caseload in cardiovascular, neurological, orthopedic, urological dermal, and soon, as preceded in this clinical trial in progess, ophthalmology:
Safety and efficacy of fibrin sealant in vitreoretinal surgery http://clinicaltrials.gov/ct2/show/NCT01022164
The criteria for patient inclusion in this trial are those having vitreoretinal procedures that require suture.
Several companies active in the area of surgical sealants [...]
Diagnostic imaging technology taking hold in ophthalmology and other clinical applications…
(Below is an excerpt from spin-off analysis from the MedMarket Diligence report #G125, "Ophthalmology Worldwide: Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Diagnostic, Device and Drug Markets Worldwide, Forecasts 2004 – 2012." This spin-off analysis is provided as a deliverable when purchasing the complete report #G125.)
–
Optical [...]
The global market for medical devices is $200 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over a 600° C temperature range of -200° C to [...]
Surgical management of soft tissues via "ablation" therapies, in which alternative energy types (radiation, electrosurgcal, ultrasound, etc.) are applied to excise, destroy, or otherwise produce a therapeutic effect at the tissue level has undergone a proliferation in development with all of these alternatives vying for caseload in clinical applications as diverse as tumor ablation, arrhythmia [...]
With late June financings by CoAxia ($21.5M), i-Therapeutix ($15M) and SynCardia Systems ($10.3M), total financings for medtech in the month of June have now passed $260 million.
Despite the lingering uncertainty in both the economy and the political sphere regarding healthcare reform legislation, and the accumulation of uninvested funds at VC firms, business goes on in [...]
Manufacturers of ablation and other energy-base therapeutics are both witnessing and driving a steady evolution of multiple technologies with potential to produce therapeutic (or, in some cases, simply cosmetic) tissue effects, with different energy types competing head-on for caseload. These innovators have continued to improve their understanding of the nature of each energy type’s impact [...]
Contact:
